Cargando…
The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study
BACKGROUND: There are limited data available on whether drug-induced hepatotoxicity (DIH) affects the clinical outcomes of tuberculosis (TB) treatment. We explored the effects of DIH on the clinical course and outcomes of pulmonary TB. METHODS: In this retrospective cohort study, we included patient...
Autores principales: | Song, Jin Hwa, Yoon, Seo-Young, Park, Tae Yun, Heo, Eun Young, Kim, Deog Kyeom, Chung, Hee Soon, Lee, Jung-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915938/ https://www.ncbi.nlm.nih.gov/pubmed/31842883 http://dx.doi.org/10.1186/s12931-019-1256-y |
Ejemplares similares
-
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
por: Heo, Eunyoung, et al.
Publicado: (2017) -
Chest computed tomography scan as an initial diagnostic method for tuberculosis infection detected by mass screening
por: Joo, Dong-Hyun, et al.
Publicado: (2021) -
Clinical implication and risk factor of pneumonia development in mild coronavirus disease 2019 patients
por: Lee, Hyun Woo, et al.
Publicado: (2021) -
Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2017) -
Discordance between MTB/RIF and Real-Time Tuberculosis-Specific Polymerase Chain Reaction Assay in Bronchial Washing Specimen and Its Clinical Implications
por: Jo, Yong Suk, et al.
Publicado: (2016)